Right-to-Try 2.0: Inside the Montana Model with Niklas Anzinger
Send us Fan Mail Episode Summary Anish Koka and Anthony DiGiorgio sit down with Niklas Anzinger, a venture capitalist and founder of Infinita VC, to unpack Montana SB535 — a new law that lets doctors administer treatments to patients that have only cleared FDA phase one trials, through licensed "experimental treatment centers" overseen by independent review boards. The conversation covers why Eroom's Law has made drug development slower and more expensive despite scientific advances, how the...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Doctors’ Lounge
The Cost Cure: Ashish Jha's Case for Price Caps, Competition, and Biosurveillance
Congressman Tom Oliverson on 340b, the No Surprises Act, gold carding, and more
Vinay Prasad: COVID, the FDA, and Why Journalism Keeps Getting Medicine Wrong
The Ship Has Sailed: Mike Munger on Medicare, Markets, and Debt
Get summaries like this every morning.
Free AI-powered recaps of The Doctors’ Lounge and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.